Biomarker Science Company Overview
- Year Founded
-
2002
- Status
-
Out of Business
- Employees
-
3
- Latest Deal Type
-
Out of Business
Biomarker Science Company General Information
Description
Developer of preventive medicines. The company develops preventive medicines for the treatment of atherosclerotic diseases, stroke and myocardial infarction.
Contact Information
Website
www.biomarker.co.jpCorporate Office
- 308 Nishikidori Karasuma Nishiirikodeyamacho
- Nakagyo-ku
- Kyoto, 604-8155
- Japan
Corporate Office
- 308 Nishikidori Karasuma Nishiirikodeyamacho
- Nakagyo-ku
- Kyoto, 604-8155
- Japan
Biomarker Science Company Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Oct-2018 | Completed | Out of Business | |||
| 1. Early Stage VC | Completed | Startup |
Biomarker Science Company Comparisons
Industry
Financing
Details
Biomarker Science Company Competitors (4)
One of Biomarker Science Company’s 4 competitors is U.S. Stem Cell, a Formerly VC-backed company based in Sunrise, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| U.S. Stem Cell | Formerly VC-backed | Sunrise, FL | ||||
| Zentiva Group | Private Equity-Backed | Prague, Czech Republic | ||||
| Mesoblast | Corporation | Melbourne, Australia | ||||
| Lisata Therapeutics | Corporation | Basking Ridge, NJ |
Biomarker Science Company Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Biomarker Science Company Patents
Biomarker Science Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2016191707-A | Method of measuring indoxylsulfuric acid | Active | 30-Mar-2015 | ||
| JP-2014167477-A | Evaluation method and evaluation kit of substance, screening method of substance, and detection method and detection kit for presence of onset of diabetic nephropathy or future onset risk | Active | 07-Apr-2014 | ||
| JP-5777227-B2 | Substance evaluation method and evaluation kit, substance screening method, presence / absence of onset of diabetic nephropathy or future onset risk detection method and detection kit | Active | 07-Apr-2014 | ||
| JP-5581432-B2 | Evaluation method and risk evaluation kit for stroke or cerebral infarction | Active | 17-Sep-2013 | ||
| JP-2013257343-A | Method of evaluating risks of developing apoplexy or cerebral infarction, and kit for evaluation thereof | Active | 17-Sep-2013 |
Biomarker Science Company Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Biomarker Science Company FAQs
-
When was Biomarker Science Company founded?
Biomarker Science Company was founded in 2002.
-
Where is Biomarker Science Company headquartered?
Biomarker Science Company is headquartered in Kyoto, Japan.
-
What is the size of Biomarker Science Company?
Biomarker Science Company has 3 total employees.
-
What industry is Biomarker Science Company in?
Biomarker Science Company’s primary industry is Biotechnology.
-
Is Biomarker Science Company a private or public company?
Biomarker Science Company is a Private company.
-
What is Biomarker Science Company’s current revenue?
The current revenue for Biomarker Science Company is .
-
Who are Biomarker Science Company’s competitors?
U.S. Stem Cell, Zentiva Group, Mesoblast, and Lisata Therapeutics are competitors of Biomarker Science Company.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
